Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine

The development of SARS-CoV-2 vaccines has raised several concerns regarding venous thromboembolism, namely cerebral venous thrombosis. Although cerebral venous thrombosis has been reported after administration of a viral vector vaccine, due to a possible auto-immune mechanism inducing thrombocytope...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of stroke and cerebrovascular diseases 2021-08, Vol.30 (8), p.105906-105906, Article 105906
Hauptverfasser:	Dias, Leonor, Soares-dos-Reis, Ricardo, Meira, João, Ferrão, Diana, Soares, Pedro Ribeirinho, Pastor, Ana, Gama, Guilherme, Fonseca, Luísa, Fagundes, Vítor, Carvalho, Marta
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Anticoagulants - therapeutic use BNT162 Vaccine Cerebral Venous Thrombosis COVID-19 COVID-19 - immunology COVID-19 - prevention & control COVID-19 - virology COVID-19 Vaccines - administration & dosage COVID-19 Vaccines - adverse effects Female Humans Middle Aged Risk Assessment Risk Factors SARS-CoV-2 Sinus Thrombosis, Intracranial - chemically induced Sinus Thrombosis, Intracranial - diagnostic imaging Sinus Thrombosis, Intracranial - drug therapy Thromboembolism Treatment Outcome Vaccination - adverse effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!